Skip to main content

Table 1 Summary of case-control populations used in this study

From: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection

 

FTICR-MS discovery

MRM validation

 

Genomics Collaborative

Seracare 1

Osaka

Chiba

Seracare 2

 

CRC

Control

CRC

Control

CRC

Control

CRC

Control

CRC

Control

Total

40

50

26

25

46

35

40

40

70

70

Male N

19

24

17

16

27

-

19

24

44

41

Male age

59 (30-78)

56 (30-78)

62 (46-80)

51 (35-70)

63 (28-90)

-

68 (45-91)

48 (36-69)

67 (39-87)

63 (32-82)

Male BMI

20.9 ± 3.8

25.0 ± 0.9

24.3 ± 5.7

25.6 ± 4.6

NA

-

NA

NA

28.0 ± 4.8

26. ± 4.2

Female N

21

26

9

9

19

-

21

16

26

29

Female age

54 (40-82)

55 (40-79)

78 (59-86)

55 (26-95)

65 (31-77)

-

70 (51-84)

49 (39-59)

73 (35-90)

56 (26-86)

Female BMI

19.9 ± 4.6

24.8 ± 2.2

23 ± 3.2

29 ± 8.0

NA

-

NA

NA

25.5 ± 4.4

24.0 ± 4.5

Stage 0/I

8

-

5

-

10

-

9

-

13

-

Stage II

16

-

8

-

14

-

18

-

21

-

Stage III

15

-

8

-

12

-

11

-

25

-

Stage IV

1

-

2

-

8

-

2

-

7

-

Unknown

0

-

3

-

2

-

0

-

4

-

  1. BMI = body mass index; CRC = colorectal cancer; FTICT-MS = Fourier transform ion cyclotron resonance mass spectroscopy; MRM = multiple reaction monitoring.